• 임상이비인후과
• /
• 제29권2호
• /
• pp.281-285
• /
• 2018

Columnar cell variant of papillary thyroid carcinoma (CCV-PTC) is a rare variant representing 0.15-0.2% of all PTCs. The CCV is aggressive, due to its rapid growth, high local recurrence rate, and frequent lung, brain and bone metastasis. Aggressive surgical and medical management are recommended for these neoplasias. The authors experienced a case of CCV-PTC in a 45-year-old man. We performed total thyroidectomy with neck dissection. The patient received radiation and radioactive iodine therapy. There were no recurrences or complications in the following 24 months after the operation. The patient will closely undergo continuous follow up. We present the clinical characteristics, pathology, treatment, and prognosis of the tumor with a review of the literature.

• 대한방사성의약품학회지
• /
• 제4권2호
• /
• pp.85-89
• /
• 2018

We demonstrate a detail protocol for the radiosynthesis of an $^{125}I$-labeled MSTP prosthetic group and its application to the efficient radiolabeling of human serum albumin (HSA). Radioiodination of the precursor (2) was carried out by using $[^{125}I]$NaI and chloramine T as an oxidant at room temperature for 15 min. After HPLC purification of the crude product, the purified $^{125}I$-labeled MSTP ($[^{125}I]1$) was obtained with high radiochemical yield ($73{\pm}5%$, n = 3) and excellent radiochemical purity (>99%). Site-specific reaction between ($[^{125}I]1$) and HSA gave the $^{125}I$-labeled human serum albumin ($[^{125}I]3$) with more than 99% of radiochemical yield as determined by radio-thin-layer chromatography (radio-TLC). These results clearly demonstrate that the present radiolabeling method will be useful for the efficient and convenient radiolabeling of thiol-bearing biomolecules.

• 방사성폐기물학회지
• /
• 제19권3호
• /
• pp.367-386
• /
• 2021

The overestimation and underestimation of the radioactivity concentration of difficult-to-measure radionuclides can occur during the implementation of the scaling factor (SF) method because of the uncertainties associated with sampling, radiochemical analysis, and application of SFs. Strict regulations ensure that the SF method as an indirect method does not underestimate the radioactivity of nuclear wastes; however, there are no clear regulatory guidelines regarding the overestimation. This has been leading to the misuse of the SF methodology by stakeholders such as waste disposal licensees and regulatory bodies. Previous studies have reported instances of overestimation in statistical implementation of the SF methodology. The analysis of the two most popular linear models of the SF methodology showed that severe overestimation may occur and radioactivity concentration data must be dealt with care. Since one major source of overestimation is the use of minimum detectable activity (MDA) values as true activity values, a comparative study of instrumental techniques that could reduce the MDAs was also conducted. Thermal ionization mass spectrometry was recommended as a suitable candidate for the trace level analysis of long-lived beta-emitters such as iodine-129. Additionally, the current status of the United States and Korea was reviewed from the perspective of overestimation.

• 방사성폐기물학회지
• /
• 제20권2호
• /
• pp.231-241
• /
• 2022

Several countries, including Korea, are considering the direct disposal of spent nuclear fuels. The radiological safety assessment results published after a geological repository closure indicate that the instant release is the main radiation source rather than the congruent release. Three Safety Case reports recently published were reviewed and the IRF values of seven long-lived radionuclides, including relevant experimental results, were compared. According to the literature review, the IRF values of both the CANDU and low burnup PWR spent fuel have been experimentally measured and used reasonably. In particular, the IRF values of volatile long-lived nuclides, such as ¹²⁹I and ¹³⁵Cs, were estimated from the FGR value. Because experimental leaching data regarding high burnup spent nuclear fuels are extremely scarce, a mathematical modelling approach proposed by Johnson and McGinnes was successfully applied to the domestic high burnup PWR spent nuclear fuel to derive the IRF values of iodine and cesium. The best estimate of the IRF was 5.5% at a discharge burnup of 55 GWd tHM^-1.

• 대한방사성의약품학회지
• /
• 제8권2호
• /
• pp.139-150
• /
• 2022

Theranostics, a composite word of therapy and diagnosis, is known as personalized medicine and the concept of diagnosis and treatment at the same time. In nuclear medicine, it means performing both therapeutic and diagnostic radioisotope therapy using the same target molecule. The increased production and utilization of ⁶⁴Cu opens a new era of theranostics. The studies introduced here have shown that ⁶⁴CuCl₂ and various compounds or biomolecules labeled with ⁶⁴Cu are unique radiopharmaceuticals with physiological properties suitable for use as diagnostic and therapeutic agents. So far, these two abilities have been described only for radioactive iodine. Although ⁶⁴Cu has complex chemical properties compared to other PET radioisotopes such as ⁶⁸Ga, it has an appropriate half-life and enables high-quality PET images similar to ¹⁸F, which is an advantage in terms of diagnosis. In addition, since it also has therapeutic properties through the release of β^- particles and Auger electrons by electron capture, radiopharmaceuticals using ⁶⁴Cu stand for innovative radiopharmaceuticals for theranostic purposes. Therefore, based on the initial results obtained using ⁶⁴Cu as a therapeutic agent, it is expected that additional research on the application of ⁶⁴Cu will lead to a new era in the theranostics field.

• Journal of Yeungnam Medical Science
• /
• 제40권1호
• /
• pp.12-22
• /
• 2023

Graves disease (GD) is the most common cause of hyperthyroidism, accounting for more than 90% of cases in Korea. Patients with GD are treated with any of the following: antithyroid drugs (ATDs), radioactive iodine (RAI) therapy, or thyroidectomy. Most patients begin treatment with ATDs, and clinical guidelines suggest that the appropriate treatment period is 12 to 18 months. While RAI treatment and surgery manage thyrotoxicosis by destroying or removing thyroid tissue, ATDs control thyrotoxicosis by inhibiting thyroid hormone synthesis and preserving the thyroid gland. Although ATDs efficiently control thyrotoxicosis symptoms, they do not correct the main etiology of GD; therefore, frequent relapses can follow. Recently, a large amount of data has been collected on long-term ATDs for GD, and low-dose methimazole (MMZ) is expected to be a good option for remission. For the long-term management of recurrent GD, it is important to induce remission by evaluating the patient's drug response, stopping ATDs at an appropriate time, and actively switching to surgery or RAI therapy, if indicated. Continuing drug treatment for an extended time is now encouraged in patients with a high possibility of remission with low-dose MMZ. It is also important to pay attention to the quality of life of the patients. This review aimed to summarize the appropriate treatment methods and timing of treatment transition in patients who relapsed several times while receiving treatment for GD.

• 대한두경부종양학회지
• /
• 제40권1호
• /
• pp.7-13
• /
• 2024

The current standard of treatment for differentiated thyroid cancer is surgical resection followed by radioactive iodine therapy according to the recurrence risk. However, external beam radiotherapy may be recommended in limited cases where surgical resection is impossible or residual gross lesion remains or the aforementioned standard therapy is deemed insufficient in achieving local control. We report a case of 59 year old patient who presented with advanced papillary thyroid carcinoma of right neck but was unable to receive surgical resection due to underlying Eisenmenger syndrome. He received radiation therapy of 67.5 Gy in 30 fractions with palliative aim with no further treatment and has been maintaining long-term stable disease state for 38 months. Herein, we report a rare case of palliative aim radiation therapy alone for advanced papillary thyroid carcinoma with literature review.

• 방사성폐기물학회지
• /
• 제2권3호
• /
• pp.181-188
• /
• 2004

방사성물질의 대기 누출 사고시 환경에서 핵종 거동을 모사하는 동적 섭식경로모델 DYNACON을 개선하여, 가축 (육우)의 공기 흡입과 토양 섭취가 육류 (쇠고기)의 방사능 오염에 미치는 영향을 고찰하였다. 이들 두 오염경로는 누출이 육우의 비방목 기간에 일어나는 경우에 육류의 오염에 있어서 결코 무시될 수 없는 경로라는 사실을 확인하였다. 특히 누출 후 대부분 기간에 걸쳐 토양 섭취에 의한 육류의 오염 영향이 공기 흡입에 의한 영향에 비해 우세하였다. 누출 기간동안 강우는 토양 섭취에 의한 육류의 오염에 중요한 요소로 작용하였으며, 이러한 현상은 단반감기 핵종인 $^{131}I$ 보다 장반감기 핵종인 $^{137}Cs$의 경우에 보다 뚜렷하였다. 이전에 수행된 우유에 대한 분석 결과와 비교하여 공기 흡입과 토양 섭취는 육류에 대해 보다 중요한 오염경로로 나타났는데, 이는 상대적으로 육류에서 핵종의 긴 생물학적 반감기 때문이다. 방목기간에 방사성물질이 대기로 누출되는 경우 누출 기간동안 강우의 유무에 관계없이 목초 섭취에 의한 오염 영향이 지배적이었으며, 결과적으로 토양 섭취와 공기 흡입에 의한 오염 영향은 우유의 경우와 마찬가지로 무시할 수 있는 수준이었다.

• 한국광물학회지
• /
• 제22권1호
• /
• pp.23-34
• /
• 2009

유기양이온(hexadecylpyridinium chloride monohydrate ($HDP^+$))으로 개질시킨 유기벤토나이트의 특성을 유기탄소함량 측정, 마이크로-X 선회절 분석, 전기영동 이동성 측정을 이용하여 관찰하고, 무처리 벤토나이트와 유기벤토나이트의 요오드에 대한 흡착성을 비교 조사하였다. 벤토나이트는 유기양이온인 $HDP^+$에 대해서 높은 친화력을 보여주었다. 마이크로-X선 회절 분석 결과에 의하면 유기벤토나이트는 저면 간격에 있어서 현저하게 팽창을 하였고, 이는 유기 양이온이 벤토나이트의 층간에 충분히 삽입되었음을 의미한다. 전기영동 이동성 측정에 의하면벤토나이트의 양이온 교환 용량 이상의 유기 양이온으로 치환시킨 유기벤토나이트의 경우 무처리 벤토나이트와 전혀다른 표면 전하분포를 나타냄을 알 수 있다. 요오드의 흡착능에 있어서, 무처리 벤토나이트는 요오드를 전혀 흡착하지 못한 반면, 벤토나이트의 양이온 교환용량의 200% 양으로 개질 시킨 유기벤토나이트의 경우 요오드 439 mmol/kg를 흡착하였다. 유기 벤토나이트에 흡착된 요오드의 분자 환경은 요오드 K-edge와 $L_{III}$-edge X-선 흡수 분광을 이용하여 연구하였다. 유기벤토나이트의 요오드 X선 흡수 변연 구조를 통해 유기벤토나이트에 흡착된 요오드의 경우 KI 표준용액의 구조와 유사함을 알 수 있었다. 광범위 X-선 흡수 미세구조의 선형 결합 분석결과는 유기 복합체와 반응한 요오드의 비율이 벤토나이트에 흡착된 유기 복합체의 양이 증가함에 따라 같이 증가함을 나타냈다. 본 연구를 통해, 벤토나이트의 개질 특성에 의해 요오드의 흡착 환경이 현저하게 달라짐을 관찰할 수 있었으며, 음이온성 방사성 요오드를 포함하는 핵폐기물 저장소 주변의 방어벽 물질로 유기벤토나이트의 적용 가능성을 살펴 볼 수 있었다.

• 핵의학기술
• /
• 제21권2호
• /
• pp.49-54
• /
• 2017

Purpose The high-dose administration of I-131 has been standing for the basic therapy method of thyroid cancer. In korea, it is not necessary for patients to be hospitalized if the administration dose are under 1.2 GBq. However, if the dose are over 1.2 GBq, the patients should be stay in special ward with radiation shield. In such cases, the radioactivity level upon release should be under a dose of $70{\mu}Sv/hr$ at a distance of approx. 1m. This regulation bring the patients to stay for about 2 to 3 days in ward before the release. Materials and Methods Using the inpatients' release data of severance hospital, an inpatient-days were retrospectively calculated and compared with practical data and estimate the inpatient-days with the conditions of korea ($70{\mu}Sv/hr$), Japan ($30{\mu}Sv/hr$), germany ($3.5{\mu}Sv/hr$ at a distance of approx. 2 m), and other european countries. Results When a effective half-life of 15.4 was used, the expected inpatient-days were calculated as 2.15 days in the condition of Japanese regulation and 1.37 days in the condition of korean regulation. The practical inpatient-days of patients in Severance hospital were 1.32 days. Conclusion As ICRP 94 has been mentioned that the release of patients administrated with I-131 for the therapy should be carefully considered because each patients has different thyroid uptake rate and their conditions with family members after the release from the ward. Nonetheless, efforts to bring more aquate data which is for getting closer to the practical data should be continuously studied.